MX9101526A - Nuevo metodo para tratar la depresion - Google Patents

Nuevo metodo para tratar la depresion

Info

Publication number
MX9101526A
MX9101526A MX9101526A MX9101526A MX9101526A MX 9101526 A MX9101526 A MX 9101526A MX 9101526 A MX9101526 A MX 9101526A MX 9101526 A MX9101526 A MX 9101526A MX 9101526 A MX9101526 A MX 9101526A
Authority
MX
Mexico
Prior art keywords
new method
treating depression
depression
treating
compounds
Prior art date
Application number
MX9101526A
Other languages
English (en)
Inventor
Jan David Wallace
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of MX9101526A publication Critical patent/MX9101526A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
MX9101526A 1990-10-12 1991-10-10 Nuevo metodo para tratar la depresion MX9101526A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/596,270 US5025035A (en) 1990-10-12 1990-10-12 Method of treating depression

Publications (1)

Publication Number Publication Date
MX9101526A true MX9101526A (es) 1992-06-05

Family

ID=24386662

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9101526A MX9101526A (es) 1990-10-12 1991-10-10 Nuevo metodo para tratar la depresion

Country Status (11)

Country Link
US (1) US5025035A (es)
EP (1) EP0552240B1 (es)
JP (1) JP3192141B2 (es)
AT (1) ATE164065T1 (es)
CA (1) CA2092416A1 (es)
DE (1) DE69129115T2 (es)
DK (1) DK0552240T3 (es)
ES (1) ES2116298T3 (es)
GR (1) GR3026519T3 (es)
MX (1) MX9101526A (es)
WO (1) WO1992006686A1 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5025035A (en) * 1990-10-12 1991-06-18 Warner-Lambert Company Method of treating depression
US5510381A (en) * 1995-05-15 1996-04-23 Warner-Lambert Company Method of treatment of mania and bipolar disorder
KR100512506B1 (ko) * 1996-03-14 2005-12-21 워너-램버트 캄파니 엘엘씨 제약제제로서신규한치환시클릭아미노산
US6372792B1 (en) 1996-04-26 2002-04-16 Guy Chouinard Method for treating anxiety, anxiety disorders and insomnia
US6001876A (en) 1996-07-24 1999-12-14 Warner-Lambert Company Isobutylgaba and its derivatives for the treatment of pain
AU9019198A (en) 1997-08-19 1999-03-08 Warner-Lambert Company Methods for treating physiological conditions associated with the use, or sequelae of use, of cocaine or other psychomotor stimulants
AU9318398A (en) 1997-10-07 1999-04-27 Warner-Lambert Company Process for preparing a cyclic amino acid anticonvulsant compound
US6635673B1 (en) * 1997-10-27 2003-10-21 Warner-Lambert Company Cyclic amino acids and derivatives thereof useful as pharmaceutical agents
HU228771B1 (en) * 1998-05-15 2013-05-28 Warner Lambert Co Stabilized pharmaceutical preparations of gamma-aminobutyric acid derivatives and process for preparing the same
BR9910494B1 (pt) * 1998-05-15 2011-11-01 composições sólidas contendo derivados de ácido gama-aminobutìrico e processo para o seu preparo.
US6992109B1 (en) * 1999-04-08 2006-01-31 Segal Catherine A Method for the treatment of incontinence
JP2002541224A (ja) * 1999-04-09 2002-12-03 ワーナー−ランバート・カンパニー うつ病の治療のためのｇａｂａ類縁体と三環系化合物の組合わせ
DK1169060T3 (da) * 1999-04-09 2006-01-16 Euro Celtique Sa Natriumkanalblokkerpræparater og anvendelse deraf
AP2002002501A0 (en) * 1999-10-07 2002-06-30 Warner Lambert Co Synergistic combinations of an NK1 receptor antagonist and a gaba structural analog.
US6531509B2 (en) 2000-06-16 2003-03-11 Teva Pharmaceutical Industries Ltd. Stable gabapentin containing more than 20 ppm of chlorine ion
PT1423168E (pt) * 2001-09-03 2006-05-31 Newron Pharm Spa Composicao farmaceutica que compreende gabapentina ou um seu analogo e uma x-aminoamida e a sua utilizacao como analgesico
ITMI20012750A1 (it) 2001-12-21 2003-06-21 Procos Spa Processo per la produzione dell'acido 1-(amminometil)-cicloesil-acetico in forma pura
US20030119908A1 (en) * 2001-12-21 2003-06-26 Zambon Group S.P.A. Stable gabapentin compositions
US20050181071A1 (en) * 2004-02-18 2005-08-18 Binder Michael R. Method for the treatment of clinical depression
ES2347581T3 (es) * 2004-09-10 2010-11-02 Newron Pharmaceuticals S.P.A. Uso de (r)-(halobenciloxi)bencilamino-propanamidas como moduladores selectivos del canal de sodio y/o calcio.
WO2011151708A1 (en) 2010-06-01 2011-12-08 Rubicon Research Private Limited Gastroretentive dosage forms of gaba analogs
WO2015144825A1 (en) 2014-03-27 2015-10-01 Sanovel Ilac Sanayi Ve Ticaret A.S. Oral liquid pharmaceutical solution of gabapentin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4087544A (en) * 1974-12-21 1978-05-02 Warner-Lambert Company Treatment of cranial dysfunctions using novel cyclic amino acids
DE2460891C2 (de) * 1974-12-21 1982-09-23 Gödecke AG, 1000 Berlin 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
US5084479A (en) * 1990-01-02 1992-01-28 Warner-Lambert Company Novel methods for treating neurodegenerative diseases
US5025035A (en) * 1990-10-12 1991-06-18 Warner-Lambert Company Method of treating depression

Also Published As

Publication number Publication date
DK0552240T3 (da) 1998-11-23
ATE164065T1 (de) 1998-04-15
DE69129115D1 (de) 1998-04-23
ES2116298T3 (es) 1998-07-16
JPH06502148A (ja) 1994-03-10
DE69129115T2 (de) 1998-07-16
EP0552240A1 (en) 1993-07-28
CA2092416A1 (en) 1992-04-13
EP0552240A4 (en) 1993-09-01
JP3192141B2 (ja) 2001-07-23
US5025035A (en) 1991-06-18
WO1992006686A1 (en) 1992-04-30
EP0552240B1 (en) 1998-03-18
GR3026519T3 (en) 1998-07-31

Similar Documents

Publication Publication Date Title
MX9101526A (es) Nuevo metodo para tratar la depresion
ES2054747T3 (es) Nuevos antidepresivos.
PT723538E (pt) Compostos triciclicos de carbamato uteis para a ainibicao da funcao da proteina g e para o tratamento de doencas proliferativas
ES2102009T3 (es) Tratamiento para el asma.
DK0471756T3 (da) Saccharinderivater, der er egnede som proteolytiske enzyminhibitorer, og fremstilling deraf
AR016981A2 (es) Polipeptidos sinteticos
ATE204851T1 (de) Verfahren zur herstellung von retrovial protease hemmenden zwischenprodukten
ATE70067T1 (de) Peptidaminoalkoholderivate, welche ein tetrasubstituiertes kohlenstoffatom besitzen, hemmungsstoffe von renin und proteasesaeuren, verfahren zur herstellung und pharmazeutische zusammensetzungen.
MX9302414A (es) Proceso para la fabricacion de pirrolidinas (s)-3-amino-1- substituidas.
DE69010294D1 (de) Verwendung von Antiprogestomimetika zur Stimulierung des Eisprungs.
ATE225171T1 (de) Aminosäurederivate zur behandlung von schlaganfall
DK0743060T3 (da) Anvendelse af tandplejemidler indeholdende bovint colostrum
ATE185137T1 (de) Verfahren zur industriellen herstellung von 4- chloro-3-sulfamoyl-n-(2,3-dihydro-2-methyl-1h- indol-1-yl)-benzamid
ES2236703T3 (es) Uso de metodos para identificar oligopeptidos de señal hidrofilos.
ES2046178T3 (es) Metodo de uso de diltiazen, verapamil o nifedipina que presentan actividad para el tratamiento de ataques de apoplejia.
DE69315730D1 (de) Verfahren zur Herstellung von Peptiden und neue Zwischenverbindungen dazu
DE59006159D1 (de) Verwendung von macrolactonen als antiallergica.
DK192890D0 (da) 24r-scumnol, fremgangsmaade til fremstilling heraf samt anvendelse af samme
ATE82124T1 (de) Anwendung von n-(2-(diaethylamino)aethyl>-2-methoxy-4((1-h-4,5ihydro-2-imidazolyl)amino>-5- chlorobenzamid als anxiolytisches und antipsychotisches mittel.
PT854862E (pt) Processo para a preparacao de um aminoacido activado
DE69925301D1 (de) Zusammensetzung von riluzol und alpha-tocopherol
ES2110671T3 (es) Procedimiento para la separacion de l-leucina y l-isoleucina de soluciones acuosas.
DE69011702D1 (de) Derivate von Aminocarboxylsäure.
BR9205877A (pt) Processo e composiçao para o tratamento de infecçoes por herpes.
DE69013062T2 (de) Verfahren zur Herstellung von Anilinofumarat via Chloromaleat oder Chlorofumarat oder Mischungen davon.